Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives
Abstract
Share and Cite
Hossain, S.M.; Carpenter, C.; Eccles, M.R. Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives. Int. J. Mol. Sci. 2024, 25, 7252. https://doi.org/10.3390/ijms25137252
Hossain SM, Carpenter C, Eccles MR. Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives. International Journal of Molecular Sciences. 2024; 25(13):7252. https://doi.org/10.3390/ijms25137252
Chicago/Turabian StyleHossain, Sultana Mehbuba, Carien Carpenter, and Michael R. Eccles. 2024. "Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives" International Journal of Molecular Sciences 25, no. 13: 7252. https://doi.org/10.3390/ijms25137252